1. Home
  2. MNKD vs WT Comparison

MNKD vs WT Comparison

Compare MNKD & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • WT
  • Stock Information
  • Founded
  • MNKD 1991
  • WT 1985
  • Country
  • MNKD United States
  • WT United States
  • Employees
  • MNKD N/A
  • WT N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • WT Investment Bankers/Brokers/Service
  • Sector
  • MNKD Health Care
  • WT Finance
  • Exchange
  • MNKD Nasdaq
  • WT Nasdaq
  • Market Cap
  • MNKD 1.4B
  • WT 1.4B
  • IPO Year
  • MNKD 2004
  • WT N/A
  • Fundamental
  • Price
  • MNKD $4.15
  • WT $9.44
  • Analyst Decision
  • MNKD Strong Buy
  • WT Buy
  • Analyst Count
  • MNKD 5
  • WT 7
  • Target Price
  • MNKD $9.40
  • WT $12.21
  • AVG Volume (30 Days)
  • MNKD 1.9M
  • WT 1.2M
  • Earning Date
  • MNKD 05-08-2025
  • WT 07-25-2025
  • Dividend Yield
  • MNKD N/A
  • WT 1.27%
  • EPS Growth
  • MNKD 228.27
  • WT N/A
  • EPS
  • MNKD 0.10
  • WT 0.37
  • Revenue
  • MNKD $297,595,000.00
  • WT $438,981,000.00
  • Revenue This Year
  • MNKD $14.36
  • WT $6.61
  • Revenue Next Year
  • MNKD $13.36
  • WT $5.61
  • P/E Ratio
  • MNKD $40.01
  • WT $25.69
  • Revenue Growth
  • MNKD 32.50
  • WT 20.66
  • 52 Week Low
  • MNKD $4.05
  • WT $7.47
  • 52 Week High
  • MNKD $7.63
  • WT $12.45
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 37.04
  • WT 54.17
  • Support Level
  • MNKD $4.07
  • WT $9.24
  • Resistance Level
  • MNKD $4.25
  • WT $9.74
  • Average True Range (ATR)
  • MNKD 0.16
  • WT 0.21
  • MACD
  • MNKD -0.03
  • WT -0.04
  • Stochastic Oscillator
  • MNKD 12.82
  • WT 29.10

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About WT WisdomTree Inc.

WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime. The Company conducts business under a single operating segment as an ETP sponsor and asset manager.

Share on Social Networks: